Volume 38, Issue 4

Search all Glycoconjugate Journal articles

August 2021

Special Issue on: Glycoconjugate vaccines: classic and novel approaches

Issue Editor:

Roberto Adamo

13 articles in this issue

Glycoconjugate vaccines: classic and novel approaches
Roberto Adamo
Editorial 25 June 2021 Pages: 397 - 398
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
In memory of Paolo Costantino (1955–2020)
Francesco Berti
Roberto Adamo
Obituary 09 January 2021 Pages: 399 - 399
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Carbohydrate based meningococcal vaccines: past and present overview
Francesco Berti
Maria Rosaria Romano
Roberto Adamo
Mini Review Open access 27 April 2021 Pages: 401 - 409
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Molecular modeling provides insights into the loading of sialic acid‐containing antigens onto CRM₁₉₇: the role of chain flexibility in conjugation efficiency and glycoconjugate architecture
Michelle M. Kuttel
Francesco Berti
Neil Ravenscroft
Original Article 15 March 2021 Pages: 411 - 419
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
The development and characterization of an E. coli O25B bioconjugate vaccine
Michael Kowarik
Michael Wetter
Michael Wacker
Original Article Open access 17 March 2021 Pages: 421 - 435
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
On the use of adenovirus dodecahedron as a carrier for glycoconjugate vaccines
Maruthi Prasanna
Malgorzata Podsiadla-Bialoskorska
Cyrille Grandjean
Original Article 14 April 2021 Pages: 437 - 446
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
Edmondo Campisi
Roberto Rosini
Immaculada Margarit
Original Artilcle Open access 06 May 2021 Pages: 447 - 457
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Mucins as anti-cancer targets: perspectives of the glycobiologist
Inka Brockhausen
Jacob Melamed
Comprehensive Review Article 11 March 2021 Pages: 459 - 474
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Glyconanoparticles as tools to prevent antimicrobial resistance
Laura Morelli
Laura Polito
Federica Compostella
Mini Review Open access 17 March 2021 Pages: 475 - 490
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Correction to: Glyconanoparticles as tools to prevent antimicrobial resistance
Laura Morelli
Laura Polito
Federica Compostella
Correction Open access 02 April 2021 Pages: 491 - 491
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Comparison of polysaccharide glycoconjugates as candidate vaccines to combat Clostridiodes (Clostridium) difficile
A.D. Cox
F. St. Michael
S.M. Logan
Original Article 13 August 2020 Pages: 493 - 508
Part of 2 collections:

Glycoconjugate vaccines: classic and novel approaches

Glycoconjugate vaccines: classic and novel approaches
Cephalosporium curvulum lectin causes mycotic keratitis by initiating infection through MyD88 dependent cellular proliferation and apoptosis in human corneal epithelial cells
Narasimhappagari Jagadeesh
Shivakumar Belur
Shashikala R. Inamdar
Original Article 19 June 2021 Pages: 509 - 516
Immunomodulatory effects of four polysaccharides purified from Erythronium sibiricum bulb on macrophages
Chunli Chen
Xiangyun Xie
Xue Li
Original Article 12 June 2021 Pages: 517 - 525

Volume 38, Issue 4

Glycoconjugate vaccines: classic and novel approaches

In memory of Paolo Costantino (1955–2020)

Carbohydrate based meningococcal vaccines: past and present overview

Molecular modeling provides insights into the loading of sialic acid‐containing antigens onto CRM₁₉₇: the role of chain flexibility in conjugation efficiency and glycoconjugate architecture

The development and characterization of an E. coli O25B bioconjugate vaccine

On the use of adenovirus dodecahedron as a carrier for glycoconjugate vaccines

Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates

Mucins as anti-cancer targets: perspectives of the glycobiologist

Glyconanoparticles as tools to prevent antimicrobial resistance

Correction to: Glyconanoparticles as tools to prevent antimicrobial resistance

Comparison of polysaccharide glycoconjugates as candidate vaccines to combat Clostridiodes (Clostridium) difficile

Cephalosporium curvulum lectin causes mycotic keratitis by initiating infection through MyD88 dependent cellular proliferation and apoptosis in human corneal epithelial cells

Immunomodulatory effects of four polysaccharides purified from Erythronium sibiricum bulb on macrophages

Navigation